ModivCare Inc. (MODV)
NASDAQ: MODV · Real-Time Price · USD
0.4400
+0.0081 (1.88%)
Aug 28, 2025, 4:00 PM - Market closed
ModivCare Revenue
ModivCare had revenue of $650.65M in the quarter ending March 31, 2025, a decrease of -4.94%. This brings the company's revenue in the last twelve months to $2.75B, down -0.70% year-over-year. In the year 2024, ModivCare had annual revenue of $2.79B with 1.32% growth.
Revenue (ttm)
$2.75B
Revenue Growth
-0.70%
P/S Ratio
0.00
Revenue / Employee
$116,316
Employees
23,675
Market Cap
6.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.79B | 36.42M | 1.32% |
Dec 31, 2023 | 2.75B | 246.78M | 9.85% |
Dec 31, 2022 | 2.50B | 507.50M | 25.41% |
Dec 31, 2021 | 2.00B | 628.22M | 45.90% |
Dec 31, 2020 | 1.37B | -141.27M | -9.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
MODV News
- 6 days ago - Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing - Business Wire
- 8 days ago - Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital - Business Wire
- 7 weeks ago - Modivcare Regains Compliance with Nasdaq Continued Listing Standard - Business Wire
- 2 months ago - Modivcare Celebrates Over a Decade of Serving Suffolk Community Member - Business Wire
- 2 months ago - ModivCare, Inc. (MODV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 2 months ago - Modivcare Releases 2024 Sustainability Report - Business Wire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ModivCare, Inc. (MODV) And Encourages Stockholders to Reach Out - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ModivCare, Inc. (MODV) And Encourages Stockholders to Connect - Accesswire